期刊
CYTOTHERAPY
卷 15, 期 9, 页码 1046-1053出版社
ELSEVIER SCI LTD
DOI: 10.1016/j.jcyt.2013.02.007
关键词
CAR; cell therapy; chimeric antigen receptor; gene therapy; targeted therapy
Adoptive cell therapy truly began with the introduction of hematopoietic stem cell transplantation. The ability to manipulate genes through cloning and expression methodologies have allowed for the development of novel chimeric receptors to selectively target cancer when introduced into immune cells. Over the past decade, gene engineered cells have been tested in clinical trials throughout the world. Recent data and striking clinical responses demonstrate the power of this new type of therapy. Current challenges include managing a potent therapy that is a dividing, rather than a static drug, safeguarding against potential toxicity, and further development to enable access to a greater number of patients.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据